India's Pharma 'IPR Stand Promotes Generic Industry Growth
February 16, 2024 11:13
GTRI report highlights India's stance on intellectual property rights (IPRs) and pharma issues in trade pacts, balancing innovation with public health needs and promoting generic drug industry growth.